Review of the PRIODAC project on thyroid protection from radioactive iodine by repeated iodide intake in individuals aged 12+

Archive ouverte

Martin, Jean-Charles | Pourcher, Thierry | Phan, Guillaume | Guglielmi, Julien | Crambes, Caroline | Caire-Maurisier, François | Lebsir, Dalila | Cohen, David | Rosique, Clément | Jing, Lun | Hichri, Maha | Salleron, Lisa | Darcourt, Jacques | Souidi, Maamar | Benderitter, Marc

Edité par CCSD ; Karger -

International audience. Background Intake of potassium iodide (KI) reduces the accumulation of radioactive iodine in the thyroid gland in the event of possible contamination by radioactive iodine released from a nuclear facility. The World Health Organization (WHO) has stated the need for research for optimal timing, appropriate dosing regimen, and safety for repetitive iodine thyroid blocking (ITB). The French PRIODAC project, addressed all these issues, involving prolonged or repeated releases of radioactive iodine. Preclinical studies established an effective dose through pharmacokinetic modeling, demonstrating the safety of repetitive KI treatment without toxicity. Summary Recent preclinical studies have determined an optimal effective dose for repetitive administration, associated with pharmacokinetic modeling. The results show the safety and absence of toxicity of repetitive treatment with KI. Good laboratory practice level preclinical studies corresponding to individuals >12 years have shown a safety margin established between animal doses without toxic effect. After approval from the French health authorities, the market authorization of the two tablets of KI, 65 mg/day, was defined with a new dosing scheme of a daily repetitive intake of the treatment up to 7 days unless otherwise instructed by the competent authorities for all categories of population except pregnant women and children under the age of 12 years. Conclusion This new marketed authorization resulting from scientific-based evidence obtained as part of the PRIODAC project may serve as an example to further harmonize the application of KI for repetitive ITB in situations of prolonged radioactive release at the European and international levels, under the umbrella of the WHO . . (C2VN), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE),

Suggestions

Du même auteur

DO MULTIPLE ADMINISTRATIONS OF STABLE IODINE PROTECT POPULATION CHRONICALLY EXPOSED TO RADIOACTIVE IODINE: WHAT IS PRIODAC RESEARCH PROGRAM (2014-22) TEACHING US?

Archive ouverte | Benderitter, Marc | CCSD

15th Coordination and Planning Meeting of the World-Health-Organization's Radiation-Emergency-Medical-Preparedness-and-Assistance-Network (WHO-REMPAN), Geneva, SWITZERLAND, JUL 03-05, 2017. International audience. S...

Metabolomics evaluation of repeated administration of potassium iodide on adult male rats

Archive ouverte | Rosique, Clément | CCSD

International audience. The long-lasting consequence of a new iodine thyroid blocking strategy (ITB) to be used in case of nuclear accident is evaluated in male Wistar rats using a metabolomics approach applied 30 d...

Impact of repeated dose of stable iodine in an in utero rat model using a metabolomic approach

Archive ouverte | Rosique, Clément | CCSD

International audience. The Fukushima nuclear power plant blast resulted in the release of 131 Iodine for several weeks. This unexpected issue challenged the iodin doctrine [1], in which the countermeasure is to pro...

Chargement des enrichissements...